ArticleJournal of managed care & specialty pharmacy2016

Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrative Claims Database.

James Harnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.